| 注册
首页|期刊导航|中国药业|2008年至2010年我院口服降糖药使用分析

2008年至2010年我院口服降糖药使用分析

谢洪梅 刘同华 黄晓 杨胜梅 枉前

中国药业2012,Vol.21Issue(20):89-90,2.
中国药业2012,Vol.21Issue(20):89-90,2.

2008年至2010年我院口服降糖药使用分析

Application Analysis of Oral Hypolycemic agents in Our Hospital during 2008-2010

谢洪梅 1刘同华 1黄晓 1杨胜梅 1枉前1

作者信息

  • 1. 中国人民解放军第三军医大学新桥医院药学部,重庆 400037
  • 折叠

摘要

Abstract

Objective To understand the use situation of oral hypolycemic agents and the trend in our hospital to provide reference for rational drug use in clinic. Methods Oral hypolycemic agents used in our hospital during 2008-2010 were performed the statistical analysis in respect of consumption sum,DDDs and DDC,etc. by the defined daily dose(DDD) method. Results The consumption sum of oral hypolycemic agents in our hospital was increased continuously. The top 3 places on the list of consumption sum were acarbose, rosiglitazone and glimepiride. The top 3 hypolycemic agents in terms of DDDs were glimepiride, rosiglitazone and metformin. The lowest DDC was glipizide. Conclusion The use of oral hypolycemic agents is increased year by year and the use of metformin is less.

关键词

口服降糖药/用药频度/日均费用/用药分析

Key words

oral hypolycemic drugs/DDDs/DDC/medication analysis

分类

管理科学

引用本文复制引用

谢洪梅,刘同华,黄晓,杨胜梅,枉前..2008年至2010年我院口服降糖药使用分析[J].中国药业,2012,21(20):89-90,2.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文